Thar Pharmaceuticals
Pittsburgh, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
RK
Raymond K. HouckPresident, Chief Executive Officer and Director of Issuer
LC
Lalit ChordiaDirector
MH
Mazen HannaChief Scientific Officer
IK
Ira KalfusChief Medical Officer of Issuer
PS
Philip SussmanDirector
RR
Robert RoyDirector
JB
Jason BablakVice President, Regulatory Affairs
BM
Brian MoyerVice President, Corporate Development & Finance
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.4MraisedApr 2016 · 18 investors · PharmaceuticalsRule 506(b)
▶$1.4MraisedApr 2016 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Raymond K. HouckExecutive Officer, Director
- Lalit ChordiaDirector
- Mazen HannaExecutive Officer
- Ira KalfusExecutive Officer
- Philip SussmanDirector
- Robert RoyDirector
- Jason BablakExecutive Officer
- Brian MoyerExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.4M
- Minimum investment
- $50K
- Proceeds to insiders
- $350K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.